![]() |
|
|
Vol. 301, Issue 2, 513-518, May 2002
Department of Psychology and Neuropsychology Doctoral Sub-Program,
City University of New York, Flushing, New York (R.M.S., H.C.G.,
M.M.H., R.J.B.); The George C. Cotzias Laboratory of Neuro-Oncology,
Memorial Sloan-Kettering Cancer Center, New York, New York (G.C.R.,
G.W.P.); and Department of Psychology, CW Post College, Long Island
University, Brookville, New York (G.C.R.)
Ventricular administration of the opioid dynorphin A1-17
induces feeding in rats. Because its pharmacological characterization has not been fully identified, the present study examined whether a
dose-response range of general and selective opioid antagonists as well
as antisense oligodeoxynucleotide (AS ODN) opioid probes altered
daytime feeding over a 4-h time course elicited by dynorphin. Dynorphin-induced feeding was significantly reduced by a wide range of
doses (5-80 nmol i.c.v.) of the selective
1-opioid
antagonist nor-binaltorphamine. Correspondingly, AS ODN probes
directed against either exons 1 and 2, but not 3 of the
-opioid
receptor clone (KOR-1) reduced dynorphin-induced feeding, whereas a
missense oligodeoxynucleotide control probe was ineffective.
Furthermore, AS ODN probes directed against either exons 1 or 2, but
not 3 of the
3-like opioid receptor clone (KOR-3/ORL-1)
also attenuated dynorphin-induced feeding. Although the selective
µ-antagonist
-funaltrexamine (20-80 nmol) reduced
dynorphin-induced feeding, an AS ODN probe directed only against exon 1 of the µ-opioid receptor clone was transiently effective. Neither
general (naltrexone, 80 nmol) nor
(naltrindole, 80 nmol)-selective
opioid antagonists were particularly effective in reducing
dynorphin-induced feeding, and an AS ODN probe targeting the individual
exons of the
-opioid receptor clone failed to significantly reduce
dynorphin-induced feeding. These converging antagonist and AS ODN data
firmly implicate the
1-opioid receptor and the KOR-1 and
KOR-3/ORL-1 opioid receptor genes in the mediation of dynorphin-induced feeding.
This article has been cited by other articles:
![]() |
L. Formisano, K.-M. Noh, T. Miyawaki, T. Mashiko, M. V. L. Bennett, and R. S. Zukin Ischemic insults promote epigenetic reprogramming of {micro} opioid receptor expression in hippocampal neurons PNAS, March 6, 2007; 104(10): 4170 - 4175. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hadjimarkou, A. Singh, Y. Kandov, Y. Israel, Y.-X. Pan, G. C. Rossi, G. W. Pasternak, and R. J. Bodnar Opioid Receptor Involvement in Food Deprivation-Induced Feeding: Evaluation of Selective Antagonist and Antisense Oligodeoxynucleotide Probe Effects in Mice and Rats J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1188 - 1202. [Abstract] [Full Text] [PDF] |
||||